Income statement, balance sheet and cash flow statement for the last 3 fiscal years, taken from the XBRL data Ceribell, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2024
FY2024
FY2025
Revenue
45.2
65.4
89.1
Cost of revenue
7.06
8.69
10.8
Gross profit
38.2
56.8
78.3
Research and development
9
13.6
19.1
Selling and marketing
38.9
49.1
73.1
General and administrative
20.3
33.8
44.5
Operating expenses
68.2
96.5
137
Operating income
-30
-39.7
-58.4
Interest expense
2.1
1.99
1.89
Other non-operating income
2.64
2.74
6.88
Pre-tax income
-29.5
-40.5
-53.4
Income tax
0.01
0
0
Net income
-29.5
-40.5
-53.4
EBITDA
-29.2
-38.6
-57.1
EPS, basic
-5.56
-3.39
-1.46
EPS, diluted
-5.56
-3.39
-1.46
Shares, basic (weighted)
5.3
11.9
36.5
Shares, diluted (weighted)
5.3
11.9
36.5
Balance sheet
FY2024
FY2024
FY2025
Cash and equivalents
34.5
194
40.5
Short-term investments
119
Receivables
7.96
10.9
15.1
Inventory
5.87
6.94
7.29
Other current assets
2.13
3.25
2.91
Total current assets
52
217
187
Property, plant and equipment
1.58
2.31
2.03
Lease right-of-use assets
2.16
2.13
2.3
Other non-current assets
1.98
2.19
2.91
Total assets
58.9
225
196
Accounts payable
0.73
1.14
2.84
Accrued liabilities
7.54
10.1
14.3
Deferred revenue
0.21
0.1
0.1
Total current liabilities
21.6
13
19.2
Long-term debt
19.6
19.8
Lease liabilities
1.68
1.31
1.36
Other non-current liabilities
0.44
0.36
0.11
Total liabilities
23.8
34.2
40.5
Paid-in capital
14.2
358
375
Retained earnings
-126
-167
-220
Other comprehensive income
0.16
Shareholders' equity
-112
191
155
Total equity
-112
191
155
Total liabilities and equity
58.9
225
196
Shares outstanding
5.43
35.9
37.5
Cash flow statement
FY2024
FY2024
FY2025
Net income
-29.5
-40.5
-53.4
Depreciation and amortization
0.85
1.14
1.34
Stock-based compensation
2.68
5.41
12.2
Change in receivables
-2.66
-2.92
-4.18
Change in inventory
-1.79
-1.07
-0.35
Change in payables
0.31
0.25
1.75
Cash from operations
-29.2
-35
-40.8
Capital expenditures
-0.98
-1.34
-0.77
Purchases of investments
0
-211
Cash from investing
-1.76
-1.6
-118
Debt issued
7.91
0
Debt repaid
-3.75
Cash from financing
-2.82
197
5.05
Net change in cash
-33.7
160
-154
Free cash flow
-30.1
-36.4
-41.6
Interest paid
1.73
1.95
1.89
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $23.69 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
88.9%
Gross profit / revenue.
Operating margin
-68.6%
Operating income / revenue.
EBITDA margin
-67.6%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-64.7%
Pre-tax income / revenue.
Net margin
-64.7%
Net income / revenue.
FCF margin
-53.7%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-53.0%
Cash from operations / revenue.
Return on equity (ROE)
-51.4%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-39.7%
Net income / average total assets.
Return on invested capital (ROIC)
-57.8%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
22.5%
Research and development expense / revenue.
Stock-based pay / revenue
16.1%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
0.7%
Capital expenditures / revenue.
D&A / revenue
1.0%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
36.1%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
37.9%
Gross profit vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
-18.7%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-13.1%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
205.8%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
9.18x
Current assets / current liabilities.
Quick ratio
8.45x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
7.52x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$1.74
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$2.68
Revenue / diluted weighted shares.
FCF per share
-$1.44
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$1.42
Cash from operations / diluted weighted shares.
Book value per share
$3.36
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
8.92x
Market cap / revenue.
P/B
7.09x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
7.09x
Market cap / tangible book value, when positive.
EV/Sales
7.65x
Enterprise value / revenue.
FCF yield
-6.0%
Free cash flow / market cap.
Earnings yield
-7.3%
Net income / market cap (the inverse of P/E).
What was Ceribell, Inc.'s revenue in fiscal 2025?
Ceribell, Inc. reported revenue of $89.1M for fiscal 2025, 36.1% higher than the year before.
Was Ceribell, Inc. profitable in fiscal 2025?
No. It reported a net loss of $53.4M.
How much free cash flow did Ceribell, Inc. generate in fiscal 2025?
Cash from operations of $40.8M minus capital expenditures of $767.0K left free cash flow of -$41.6M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.